Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea Optics

July 6, 2026 6:46 AM
Cantor Fitzgerald analyst Carter Gould lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $750.00 (from $785.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change